Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2025-12-26 @ 11:07 AM
Study NCT ID:
NCT01137812
Status:
COMPLETED
Last Update Posted:
2015-01-15
First Post:
2010-06-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07
Start Date Type:
None
Primary Completion Date:
2012-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-03
First Submit QC Date:
None
Study First Post Date:
2010-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-02
Results First Submit QC Date:
None
Results First Post Date:
2013-05-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-06-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-01-05
Last Update Post Date:
2015-01-15
Last Update Post Date Type:
ESTIMATED